The creation of therapeutic or prophylactic drugs based on mRNA cannot yet lead to high-quality results, said the head of the Institute. N. F. Gamalei, Academician of the Russian Academy of Sciences Alexander Gintsburg.
.
The creation of therapeutic or prophylactic drugs based on mRNA cannot yet lead to high-quality results, said the head of the Institute. N. F. Gamalei, Academician of the Russian Academy of Sciences Alexander Gintsburg.
.